A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants
Clinical trial NCT07222709 · RECRUITING
Trial details
- NCT number
- NCT07222709
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-27
- Primary completion
- 2026-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.